German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...

German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...

Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial ...

Evotec and Novo Nordisk have partnered to develop off-the-shelf cell therapy products. The collaboration will focus on ...

Hamburg, Germany, 26 September 2024: Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that Evotec has entered a technology development ...

Evotec has entered a partnership with Novo Nordisk to develop next-generation off-the-shelf cell therapy technologies. Novo ...

While the companies did not reveal the financial details of the deal, Novo Nordisk will provide funding for two Evotec sites ...

Shares of Evotec (ETR: EVTG)rose on Thursday after the company said it has entered a technology development partnership with ...

Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.

This summary covers key developments in the pharmaceutical sector, including Pfizer's initiatives in low-income nations, challenges faced by Canadian provinces in drug treatment policies, major trial ...

European stocks closed higher on Thursday amid optimism the Chinese government will announce more stimulus measures to help spur ...

EU mid-market update: Ceasefire on the cards for Israel/Lebanon; China reiterates forceful rate cuts; Focus on Powell, weekly ...